Depreciation of Aurinia Pharmaceuticals Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aurinia Pharmaceuticals Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Aurinia Pharmaceuticals Inc. Depreciation for the quarter ending 31 Mar 2024 was $4,847,000, a 576% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Depreciation for 2025 was $600,000, unchanged from 2024.
  • Aurinia Pharmaceuticals Inc. annual Depreciation for 2024 was $600,000, unchanged from 2023.
  • Aurinia Pharmaceuticals Inc. annual Depreciation for 2023 was $600,000, unchanged from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Aurinia Pharmaceuticals Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $600,000 $0 0% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $600,000 $0 0% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $600,000 $0 0% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $600,000 -$63,000 -9.5% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $663,000 +$581,000 +709% 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2024 2023 FY
2020 $82,000 +$49,000 +148% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $33,000 +$13,000 +65% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $20,000 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY

Aurinia Pharmaceuticals Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $4,847,000 +$4,130,000 +576% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q1 2023 $717,000 +$30,000 +4.4% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $662,000 $687,000 -$1,000 -0.14% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $663,000 $425,000 -$495,000 -707% 01 Oct 2021 31 Dec 2021 10-K 15 Feb 2024 2023 FY
Q3 2021 $1,158,000 $200,000 +$200,000 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $958,000 $200,000 +$200,000 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $758,000 $688,000 +$676,000 +5633% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $82,000 $70,000 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $0 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 $0 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $12,000 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.